Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-031086
Filing Date
2021-08-02
Accepted
2021-08-02 20:02:54
Documents
2
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3189
2 EX-24 DOCUMENT attachment1.htm EX-24 4591
  Complete submission text file 0000899243-21-031086.txt   9300
Mailing Address C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address
Caffo Nathan (Reporting) CIK: 0001816992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 211137471

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)